BREAKING NEWS

Teva reaches agreement to resolve pending tax litigations for $750 million

Teva Pharmaceutical Industries said on Tuesday it has entered an agreement with the Israel Tax Authority to resolve all pending litigation regarding taxes payable for the years from 2008 to 2020.

Under the agreement, the Israel-based company will pay $750 million in installments between 2024 and 2029.